¤é´Á |
¿³ÂdªÑ²¼¤½¥q¦WºÙ |
·s»D¼ÐÃD |
2022/11/29 | «CªQ°·±d ¿³ | ¤½§i¥»¤½¥q111¦~²Ä¤@¦¸ªÑªFÁ{®É·|«n¨Mij¨Æ¶µ |
1.¨Æ¹êµo¥Í¤é:111/11/292.µo¥Í½t¥Ñ:¥»¤½¥q111¦~²Ä¤@¦¸ªÑªFÁ{®É·|«n¨Mij¨Æ¶µ¤@¡BªÑªF·|¤é´Á¡G111/11/29¤G¡B°Q½×¨Æ¶µ (¤@)³q¹L¥»¤½¥q¡u¤½¥q³¹µ{¡v³¡¤À±ø¤å×q®× (¤G)³q¹L¥»¤½¥q¡uI®Ñ«OÃÒ§@·~µ{§Ç¡v³¡¤À±ø¤å×q®× (¤T)³q¹L¥»¤½¥q¡u¸êª÷¶U»P¥L¤H³B²zµ{§Ç¡v³¡¤À±ø¤å×q®× (¥|)³q¹L¥»¤½¥q¡u¨ú±o©Î³B¤À¸ê²£³B²zµ{§Ç¡v³¡¤À±ø¤å×q®× (¤)³q¹L¥»¤½¥q¥»¤½¥q¡uªÑªF·|ij¨Æ³W«h¡v×q®× (¤»)³q¹L¥»¤½¥q¥»¤½¥q¡u¸³¨Æ¿ï¥ôµ{§Ç¡vq©w®×¤T¡B¿ïÁ|¨Æ¶µ: (¤@)¿ï¥ô¿W¥ß¸³¨Æ®×¥|¡B¨ä¥L°Q½×¨Æ¶µ: (¤@)¸Ñ°£¿W¥ß¸³¨ÆÄv·~¸T¤î¤§¨î®×3.¦]À³±¹¬I:¤£¾A¥Î4.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | «CªQ°·±d ¿³ | ¤½§i¥»¤½¥q111¦~²Ä1¦¸ªÑªFÁ{®É·|¼W¿ï¤T®u¿W¥ß¸³¨Æº[ ¸³¨ÆÅÜ |
¤½§i¥»¤½¥q111¦~²Ä1¦¸ªÑªFÁ{®É·|¼W¿ï¤T®u¿W¥ß¸³¨Æº[ ¸³¨ÆÅܰʹF¤T¤À¤§¤@ 1.µo¥ÍÅܰʤé´Á:111/11/292.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¤£¾A¥Î3.·s¥ôªÌ©m¦W¤Î²¾ú:¿W¥ß¸³¨Æ¡G¤ý·¶» ³Á®æ·|p®v¨Æ°È©Ò ©Òªø ®¶¦t¤ª÷ªÑ¥÷¦³¤½¥q¿W¥ß¸³¨Æ Ä_¤¸¼Æ±±ªÑ¥÷¦³¤½¥q¿W¥ß¸³¨Æ¿W¥ß¸³¨Æ¡G³¯µØ©ú «ß§öÂåÃĺ[°Ó°Èªk«ß¨Æ°È©Ò ©Òªø¿W¥ß¸³¨Æ¡G¿à²KºÖ °]¹Îªk¤H]®ß¿¤¨p¥ß®ü«C¦Ñ¤H¾iÅ@¤¤¤ß °õ¦æªø4.²§°Êì¦]:111¦~²Ä¤@¦¸ªÑªFÁ{®É·|¼W¿ï¤T®u¿W¥ß¸³¨Æ5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ¾ºÙ ©m¦W ¿ï¥ô®É«ùªÑ¼Æ(ªÑ)¿W¥ß¸³¨Æ¡G¤ý·¶» 0¿W¥ß¸³¨Æ¡G³¯µØ©ú 0¿W¥ß¸³¨Æ¡G¿à²KºÖ 06.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:111/06/16~114/06/157.·s¥ô¥Í®Ä¤é´Á:@111/11/298.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:@4/79.¨ä¥LÀ³±Ô©ú¨Æ¶µ:³¯¤¯¹ü¸³¨Æ¦Û111/11/28°_Ãã¥ô¸³¨Æ¤@¾¡C¥»¤½¥q¬°³]¸m¼fp©eû·|´À¥NºÊ¹î¤H¤§Â¾Åv¡A§ï¬°¤C®u¸³¨Æ¡A¨ä¤¤¥]§t¤T®u¿W¥ß¸³¨Æ¡A¥Ñ¥þÅé¿W¥ß¸³¨Æ²Õ¦¨¼fp©eû·|¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ´µ¨ä¤j¬ì ¿³ | ¥N¥»¤½¥q¤§«n¤l¤½¥qµØ·s»ö¿ö(ªÑ)¤½¥q ¤½§iÁ`¸g²z²§°Ê |
1.¸³¨Æ·|¨Mij¤é´Á©Îµo¥ÍÅܰʤé´Á:111/11/292.¤Hû§O¡]½Ð¿é¤J¸³¨Æªø©ÎÁ`¸g²z¡^:Á`¸g²z3.ÂÂ¥ôªÌ©m¦W:¨ô¼üÂò4.ÂÂ¥ôªÌ²¾ú:´µ¨ä¤j¬ì§Þ(ªÑ)¤½¥q/Á`¸g²z¡A µØ·s»ö¿ö(ªÑ)¤½¥q/Á`¸g²z¡A ¥xÆW¸ê®Æ¬ì¾Ç(ªÑ)¤½¥q/Á`¸g²z5.·s¥ôªÌ©m¦W:«Ý©e¥ô¡C6.·s¥ôªÌ²¾ú:¤£¾A¥Î¡C7.²§°Ê±¡§Î¡]½Ð¿é¤J¡uÃ㾡v¡B¡u¸Ñ¥ô¡v¡B¡u¥ô´Á©¡º¡¡v¡B¡u¾°È½Õ¾ã¡v¡B¡u¸ê»º¡v¡B¡u°h¥ð¡v¡B¡u³u¥@¡v©Î¡u·s¥ô¡v¡^:Ãã¾8.²§°Êì¦]:Ó¤H¥Í²P³W¹º¡C9.·s¥ô¥Í®Ä¤é´Á:¤£¾A¥Î¡C10.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µØ·s»ö¿ö©ó111¦~11¤ë29¤é±µÀòÃã¥ô®Ñ¡A¥Í®Ä¤é111¦~12¤ë09¤é¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ´µ¨ä¤j¬ì ¿³ | ¤½§i¥»¤½¥qÁ`¸g²z²§°Ê |
1.¸³¨Æ·|¨Mij¤é´Á©Îµo¥ÍÅܰʤé´Á:111/11/292.¤Hû§O¡]½Ð¿é¤J¸³¨Æªø©ÎÁ`¸g²z¡^:Á`¸g²z3.ÂÂ¥ôªÌ©m¦W:¨ô¼üÂò4.ÂÂ¥ôªÌ²¾ú:´µ¨ä¤j¬ì§Þ(ªÑ)¤½¥q/Á`¸g²z¡A µØ·s»ö¿ö(ªÑ)¤½¥q/Á`¸g²z¡A ¥xÆW¸ê®Æ¬ì¾Ç(ªÑ)¤½¥q/Á`¸g²z5.·s¥ôªÌ©m¦W:«Ý©e¥ô¡C6.·s¥ôªÌ²¾ú:¤£¾A¥Î¡C7.²§°Ê±¡§Î¡]½Ð¿é¤J¡uÃ㾡v¡B¡u¸Ñ¥ô¡v¡B¡u¥ô´Á©¡º¡¡v¡B¡u¾°È½Õ¾ã¡v¡B¡u¸ê»º¡v¡B¡u°h¥ð¡v¡B¡u³u¥@¡v©Î¡u·s¥ô¡v¡^:Ãã¾8.²§°Êì¦]:Ó¤H¥Í²P³W¹º¡C9.·s¥ô¥Í®Ä¤é´Á:¤£¾A¥Î¡C10.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¥»¤½¥q©ó111¦~11¤ë29¤é±µÀòÃã¥ô®Ñ¡A¥Í®Ä¤é111¦~12¤ë09¤é¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ºa¬´¬ì§Þ ¿³ | ¤½§i¥»¤½¥q°]°Èº[·|p¥DºÞ¤Î¥N²zµo¨¥¤H²§°Ê |
1.¤HûÅܰʧO¡]½Ð¿é¤Jµo¨¥¤H¡B¥N²zµo¨¥¤H¡B«nÀç¹B¥DºÞ(¦p:°õ¦æªø¡BÀç¹Bªø¡B¦æ¾Pªø¤Îµ¦²¤ªøµ¥)¡B¶D³^¤Î«D¶D³^¥N²z¤H¡B°]°È¥DºÞ¡B·|p¥DºÞ¡B¤½¥qªv²z¥DºÞ¡B¸ê°T¦w¥þªø¡B¬ãµo¥DºÞ©Î¤º³¡½]®Ö¥DºÞ¡^:°]°Èº[·|p¥DºÞ¤Î¥N²zµo¨¥¤H2.µo¥ÍÅܰʤé´Á:111/11/293.ÂÂ¥ôªÌ©m¦W¡B¯Å¾¤Î²¾ú:ùÐw¬À/ºa¬´¬ì§Þ(ªÑ)¤½¥q°]°È³Bªø4.·s¥ôªÌ©m¦W¡B¯Å¾¤Î²¾ú:¶d¬üµ×/ºa¬´¬ì§Þ(ªÑ)¤½¥q°]°È¸ê²`¸g²z5.²§°Ê±¡§Î¡]½Ð¿é¤J¡uÃ㾡v¡B¡u¾°È½Õ¾ã¡v¡B¡u¸ê»º¡v¡B¡u°h¥ð¡v¡B¡u¦º¤`¡v¡B¡u·s¥ô¡v©Î¡u¸Ñ¥ô¡v¡^:¾°È½Õ¾ã6.²§°Êì¦]:¾°È½Õ¾ã7.¥Í®Ä¤é´Á:111/11/298.¨ä¥LÀ³±Ô©ú¨Æ¶µ:°]°Èº[·|p¥DºÞ¤Î¥N²zµo¨¥¤H¦Û111/11/29°_±N¥Ñ¶d¬üµ×¸g²z¼È¥N¡A«S¸³¨Æ·|¥¿¦¡³q¹L¥ô©R«á¥t¦æ¤½§i¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ¥þºÖ¥Íª« ¿³ | ¤½§i¥»¤½¥q¶}µo¤¤·sÃÄBRM424Àò¬ü°êFDA¼f¬d³qª¾±Â¤©©t¨à |
¤½§i¥»¤½¥q¶}µo¤¤·sÃÄBRM424Àò¬ü°êFDA¼f¬d³qª¾±Â¤©©t¨àÃÄ ¸ê®æ»{©w 1.¨Æ¹êµo¥Í¤é:111/11/292.¤½¥q¦WºÙ:¥þºÖ¥Íª«¬ì§ÞªÑ¥÷¦³¤½¥q3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î5.µo¥Í½t¥Ñ: ¥»¤½¥q©ó111¦~11¤ë29¤é(¥xÆW®É¶¡)±µÀò¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)³qª¾¡A¶}µo¤¤·sÃÄ BRM424¡A¤w³q¹L¬ü°êFDA¼f¬d¡A±Â¤©¥Î©óªvÀø¯«¸gÀç¾i©Ê¨¤½¤ª¢(Neurotrophic Kera- titis)©t¨àÃĸê®æ»{©w(Orphan Drug Designation, ODD)¡C®Ú¾Ú³o¶µ¸ê®æ»{©w¡A¥»¤½ ¥q¥i¥HÀò±o¬ü°êFDAµ¹¤©§ó¦h¦æ¬F¨ó§U¡BÁ{§É¬ãµo¶O¥Î¸É§U¡B§K°£·sÃĥӽгW¶O»P´î µ|¡B¥[³t¼f¬d¤ÎÉ]³õ±M½æ«OÅ@´Áµ¥Àu´f±¹¬I¡F¥¼¨ÓBRM424Àò±o¤WÉ]³\¥i«á¡A±N¨É¦³¤C ¦~ªº¬ü°êÉ]³õ±M½æ¿W¦ûÅv¡C6.¦]À³±¹¬I:µL¡C7.¨ä¥LÀ³±Ô©ú¨Æ¶µ: (¤@)¬ãµo·sÃĦWºÙ©Î¥N¸¹¡GBRM424 (¤G)¥Î³~¡GBRM424¥Î©óªvÀø¯«¸gÀç¾i©Ê¨¤½¤ª¢¯e¯f¡C (¤T)¹wp¶i¦æ¤§©Ò¦³¬ãµo¶¥¬q¡G¤G´ÁÁ{§É¸ÕÅç¡C (¥|)¥Ø«e¶i¦æ¤¤¤§¬ãµo¶¥¬q¡G (1)´£¥X¥Ó½Ð/³q¹L®Öã/¤£³q¹L®Öã/¦U´Á¤HÅéÁ{§É¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG/µo¥Í¨ä ¥L¼vÅT·sÃĬãµo¤§«¤j¨Æ¥ó¡G¨ú±o¬ü°êFDA©t¨àÃĸê®æ»{©w¡A´£¥X¥Ó½Ð¬ü°ê¤G ´ÁÁ{§É¸ÕÅç¡A¨Ã¿n·¥´M§ä±ÂÅv¦X§@¹ï¶H¡C (2)¥¼³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥i¡B¦U´Á¤HÅéÁ{§É¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG¥¼¹F²Îp ¤WÅãµÛ·N¸q©Îµo¥Í¨ä¥L¼vÅT·sÃĬãµo¤§«¤j¨Æ¥óªÌ¡A¤½¥q©Ò±Á{¤§·ÀI¤Î¦]À³ ±¹¬I¡G¤£¾A¥Î¡C (3)¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥i¡B¦U´Á¤HÅéÁ{§É¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG¹F²Îp¤W ÅãµÛ·N¸q©Îµo¥Í¨ä¥L¼vÅT·sÃĬãµo¤§«¤j¨Æ¥óªÌ¡A¥¼¨Ó¸gÀç¤è¦V¡G¥»¤½¥q«áÄò ±N³W¹º¥Ó½Ð°õ¦æ¬ü°ê¤G´ÁÁ{§É¸ÕÅç¡A¨Ã¿n·¥´M§ä±ÂÅv¦X§@¹ï¶H¡C (4)¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G¦]À³¥¼¨Ó°ê»Ú±ÂÅv½Í§Pµ¦²¤¤Î«O»Ù§ë¸ê¤HÅv¯q¡A¬G¤£ ¤©´¦ÅS¡C (¤)±N¦A¶i¦æ¤§¤U¤@¬ãµo¶¥¬q¡G (1)¹wp§¹¦¨®É¶¡¡G±N¶i¤J¤G´ÁÁ{§É¸ÕÅç¡A±©¹ê»Ú®Éµ{±N¨Ì°õ¦æ¶i«×½Õ¾ã¡C (2)¹wpÀ³t¾á¤§¸q°È¡G¤£¾A¥Î¡C (¤»)É]³õ²{ªp¡G ¯«¸gÀç¾i©Ê¨¤½¤ª¢¬O¤@ºØ¨u¨£°h¦æ©Ê¡BP´Ý©Ê²´¯e¡C¥Dn¯f²zì¦]¬O¤T¤e¯«¸g¨ü·l ¡Aµo¯f²v¤£¨ì¸U¤À¤§¤¡A¤T¤e¯«¸g¯fÅÜ¥i³y¦¨¨¤½¤·Pıªº¶Ç¤J¯«¸g²§±`©Î¤¤Â_¡A¨Ï µLªkºû«ù¨¤½¤¤W¥Ö¼h¤§§¹¾ã©Ê¡A¦Ó¥X²{«ù¤[©Ê¡B¤ÏÂЩʨ¤½¤·l¶Ë¡C¯f¤H³q±`±q¨¤½¤ ÅÜÁ¡¡B¼ìºÅ¶}©l¡A¨Ã¥¢¥h·Pı¡AÄY«®É¨¤ ½¤¶}©l·»¸Ñ¤Î¬ï¤Õ¡A¬Æ¦Ü¼vÅTµø¤O¾ÉP ¥¢©ú¡C¦bÁ{§É¤W¡A¯«¸gÀç¾i©Ê¨¤½¤ª¢ªvÀø«D±`½ÆÂø¡A¥ç¯Ê¥F¦³®ÄªvÀø¤èªk¡A¬°²´¨¤ ½¤³Ð¶Ë¤¤³ÌÃø¡¦X»PªvÀøªº¯e¯f¡A³q±`ªvÀø¤è¦¡¬°®ø·¥ªºÂI¤H¤u²\²G¡A¿n·¥ªvÀø¤è ¦¡¬°«I¤J©Ê¤§¥~¬ì¤â³N¡C®Ú¾ÚTRANSPARENCY MARKET RESEARCH¸ê®ÆÅã¥Ü¡A116¦~¯« ¸gÀç¾i©Ê¨¤½¤ª¢ªº¥þ²y¥Dn¥«³õ¬°3.24»õ¬ü¤¸¡A108¦~~116¦~§¡½Æ¦X¼Wªø²v(CGAR) ¬°17%¡C ¥Ø«e°ß¤@©ó¬ü°ê¤Î¼Ú¬w¤W¥«¤§ªvÀø¯«¸gÀç¾i©Ê¨¤½¤ª¢ÃÄ«~ Oxervate (Cenegermin) ©ó107¦~¸g¬ü°êFDA®Öã¡A¨C¤Ñµ¹¤©6¦¸¡A¨Ã«ùÄò¤K¶g¡A¥BÃÄ»ù©ù¶Q¡A¨Ã«D¦h¼Æ¯f¤H ¥it¾á¤§¶O¥Î¡C (¤C)·sÃĶ}µo®Éµ{ªø¡A§ë¤J¸g¶O°ª¥B¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A§ë ¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ¤¯·sÂåÃÄ ¿³ | ¥»¤½¥q¨üÁÜ°Ñ¥[¤¸´IÃÒ¨é¤ÎÀô²y¥Í§Þ¤ë¥ZÁ|¿ì¤§ªk¤H»¡©ú·| |
²Å¦X±ø´Ú²ÄXX´Ú¡G30¨Æ¹êµo¥Í¤é¡G111/12/011.¥l¶}ªk¤H»¡©ú·|¤§¤é´Á¡G111/12/012.¥l¶}ªk¤H»¡©ú·|¤§®É¶¡¡G14 ®É 00 ¤À 3.¥l¶}ªk¤H»¡©ú·|¤§¦aÂI¡G«n´ä®iÄý¤@À]401ÆU4.ªk¤H»¡©ú·|¾Ün°T®§¡G¥»¤½¥q¨üÁÜ°Ñ¥[¤¸´IÃÒ¨é¤ÎÀô²y¥Í§Þ¤ë¥ZÁ|¿ì¤§ªk¤H»¡©ú·|5.ªk¤H»¡©ú·|²³ø¤º®e¡G¤º®eÀɮשó·í¤é·|«á¤½§i©ó¤½¶}¸ê°TÆ[´ú¯¸6.¤½¥qºô¯¸¬O§_¦³´£¨Ñªk¤H»¡©ú·|¤º®e¡G¦³¡Aºô§}¡G www.linbioscience.com/Investors/Investor#anchor7.¨ä¥LÀ³±Ô©ú¨Æ¶µ¡G¬ÛÃö¸ê°T½Ð¦Ü¤½¶}¸ê°TÆ[´ú¯¸¤§ªk¤H»¡©ú·|¤@Äýªí©Îªk»¡·|¶µ¥Ø¤U¬d¾\¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | §»ùÖ¹CÀ¸ ¿³ | ¤½§i¥»¤½¥q111¦~²{ª÷¼W¸ê¦¬¨¬ªÑ´Úº[¼W¸ê°ò·Ç¤é |
1.¨Æ¹êµo¥Í¤é:111/11/292.¤½¥q¦WºÙ:§»ùÖ¹CÀ¸ªÑ¥÷¦³¤½¥q3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î5.µo¥Í½t¥Ñ:¨Ì¾Ú¡uµo¦æ¤H¶Ò¶°»Pµo¦æ¦³»ùÃÒ¨é³B²z·Ç«h¡v³W©w¿ì²z¤½§i6.¦]À³±¹¬I:µL7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:(1)¥»¤½¥q111¦~²{ª÷¼W¸êµo¦æ´¶³qªÑ10,000¥aªÑ¡A¨CªÑµo¦æ»ù®æ·s¥x¹ô73¤¸¡A ¹ê¦¬ªÑ´ÚÁ`ÃB·s¥x¹ô730,000¥a¤¸¡A·~¤w¥þ¼Æ¦¬¨¬¡C(2)¥»¤½¥qq©w111¦~11¤ë29¤é¬°¼W¸ê°ò·Ç¤é¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | êMÁp¿ûÅK ¿³ | ¤½§i¥»¤½¥q§t¦C¤J¦X¨Ö°]°È³ø§i¤§¤l¤½¥q111¦~10¤ë31¤é¦Ûµ² |
¤½§i¥»¤½¥q§t¦C¤J¦X¨Ö°]°È³ø§i¤§¤l¤½¥q111¦~10¤ë31¤é¦Ûµ²³øªí ¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v¡B³t°Ê¤ñ²v¡B»È¦æ¿Ä¸êÃB«×¨Ï¥Î±¡§Î¤Î ¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î¡C 1.¨Æ¹êµo¥Í¤é:111/11/292.¤½¥q¦WºÙ:êMÁp¿ûÅKªÑ¥÷¦³¤½¥q3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î5.µo¥Í½t¥Ñ:¨Ì¤¤µØ¥Á°êÃÒ¨éÂdÂi¶R½æ¤¤¤ßÃÒÂdºÊ¦r²Ä0980200246¸¹¨ç ¤ÎÃÒÂd¼f¦r²Ä1080006916¸¹¨ç¿ì²z¤½§i¡C (1)¥»¤½¥q111¦~10¤ë©³¤î¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v¤Î³t°Ê¤ñ²v¦p¤U: t¶Å¤ñ²v 62.44% ¬y°Ê¤ñ²v 65.88% ³t°Ê¤ñ²v 29.49% (A)t¶Å¤ñ²v=(t¶ÅÁ`ÃB / ¸ê²£Á`ÃB ) (B)¬y°Ê¤ñ²v=(¬y°Ê¸ê²£ / ¬y°Êt¶Å ) (C)³t°Ê¤ñ²v=(¬y°Ê¸ê²£-¦s³f-¹w¥I´Ú¶µ / ¬y°Êt¶Å ) (2)¥»¤½¥qºI¦Ü111¦~10¤ë©³¤î»È¦æ¿Ä¸êÃB«×¨Ï¥Î±¡§Î(³æ¦ì¡G¥a¤¸) ¶µ¥Ø ¹ô§O ¿Ä¸êÃB«× ¤w¥ÎÃB«× ¥¼¨Ï¥ÎÃB«× ------------------------------------------------------- ªø´ÁÉ´Ú NTD 12,592,877 11,424,344 1,168,533 µu´ÁÉ´Ú NTD 23,439,735 16,419,602 7,020,133 (3)¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î (³æ¦ì¡G¥a¤¸) ¶µ¥Ø/¤ë¥÷ 111¦~12¤ë 112¦~01¤ë 112¦~02¤ë ------------------------------------------------------- ´Áªì¾lÃB 1,846,960 2,184,738 2,159,975 ²{ª÷¬y¤J 4,743,252 4,575,787 4,517,416 ²{ª÷¬y¥X 4,405,474 4,600,550 4,859,411 ´Á¥½¾lÃB 2,184,738 2,159,975 1,817,9806.¦]À³±¹¬I:¨Ì¥DºÞ¾÷Ãö³W©w¤½§i7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ¥ú¹©¥Íª« ¿³ | ¥»¤½¥q¨üÁÜ°Ñ¥[¤¸´IÃÒ¨é¤ÎÀô²y¥Í§Þ¤ë¥ZÁ|¿ì¤§ªk¤H»¡©ú·| |
²Å¦X±ø´Ú²ÄXX´Ú¡G30¨Æ¹êµo¥Í¤é¡G111/12/011.¥l¶}ªk¤H»¡©ú·|¤§¤é´Á¡G111/12/012.¥l¶}ªk¤H»¡©ú·|¤§®É¶¡¡G14 ®É 00 ¤À 3.¥l¶}ªk¤H»¡©ú·|¤§¦aÂI¡G«n´ä®iÄý¤@À]401ÆU4.ªk¤H»¡©ú·|¾Ün°T®§¡G¥»¤½¥q¨üÁÜ°Ñ¥[¤¸´IÃÒ¨é¤ÎÀô²y¥Í§Þ¤ë¥ZÁ|¿ì¤§ªk¤H»¡©ú·|5.ªk¤H»¡©ú·|²³ø¤º®e¡G¤º®eÀɮשó·í¤é·|«á¤½§i©ó¤½¶}¸ê°TÆ[´ú¯¸6.¤½¥qºô¯¸¬O§_¦³´£¨Ñªk¤H»¡©ú·|¤º®e¡G¦³¡Aºô§}¡G www.bioptic.com.tw/7.¨ä¥LÀ³±Ô©ú¨Æ¶µ¡G¬ÛÃö¸ê°T½Ð¦Ü¤½¶}¸ê°TÆ[´ú¯¸¤§ªk¤H»¡©ú·|¤@Äýªí©Îªk»¡·|¶µ¥Ø¤U¬d¾\<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | µØ¿Ý¹ç ¿³ | ¤½§i111¦~10¤ë¥÷¦Ûµ²°]°È³ø§i¤§t¶Å¤ñ²v.¬y°Ê¤ñ²v¤Î³t°Ê¤ñ |
¤½§i111¦~10¤ë¥÷¦Ûµ²°]°È³ø§i¤§t¶Å¤ñ²v.¬y°Ê¤ñ²v¤Î³t°Ê¤ñ²v 1.¨Æ¹êµo¥Í¤é:111/11/292.µo¥Í½t¥Ñ:Âd¶R¤¤¤ßÃÒÂd¼f¦r²Ä1080100966¸¹¨çn¨D¿ì²z¤½§i3.°]°È¸ê°T¦~«×¤ë¥÷:111¦~10¤ë¥÷4.¦Ûµ²¬y°Ê¤ñ²v:136.84%5.¦Ûµ²³t°Ê¤ñ²v:67.01%6.¦Ûµ²t¶Å¤ñ²v:69.61%7.¦]À³±¹¬I:¨Ì«ö´Á¤½§i¡C8.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ¦w²±¥Í¬ì ¿³ | ¤½§i¥»¤½¥q¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î ¤Î»È¦æ¥i¨Ï¥Î¿Ä¸êÃB«×±¡ |
¤½§i¥»¤½¥q¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î ¤Î»È¦æ¥i¨Ï¥Î¿Ä¸êÃB«×±¡§Î 1.¨Æ¹êµo¥Í¤é:111/11/292.¤½¥q¦WºÙ:¦w²±¥Í¬ì(ªÑ)¤½¥q3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î5.µo¥Í½t¥Ñ:Âd¶R¤¤¤ß©ó110¦~12¤ë17¤éÃÒÂd¼f¦r²Ä1100071046¸¹¨ç¿ì²z(1)¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î (³æ¦ì¡G¥a¤¸)¶µ¥Ø/¤ë¥÷ 111¦~12¤ë 112¦~01¤ë 112¦~02¤ë--------------------------------------------------------------´Áªì¾lÃB 47,085 44,567 45,313²{ª÷¬y¤J 4,840 8,070 9,423²{ª÷¬y¥X 7,358 7,324 7,152´Á¥½¾lÃB 44,567 45,313 47,584(2)¥»¤½¥q111¦~ºI¦Ü10¤ë©³¤î»È¦æ¥i¨Ï¥Î¿Ä¸êÃB«×±¡§Î (³æ¦ì¡G¥a¤¸)¶µ¥Ø ¹ô§O ¿Ä¸êÃB«× ¤w¥ÎÃB«× ¥¼¨Ï¥ÎÃB«×--------------------------------------------------------------µu´ÁÉ´Ú NTD 0 0 0ªø´ÁÉ´Ú NTD 0 0 06.¦]À³±¹¬I:¤£¾A¥Î7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¥»¤½¥q«YÄݥͧ޲£·~¨ã§ë¸ê·ÀI¡A¦³Ãö°]°È¤ÎÀ禬¸ê°T½Ð¨Ì¤½¶}¸ê°TÆ[´ú¯¸¸ê®Æ¬°·Ç¡A§ë¸ê¤H½Ð¼f·V§PÂ_ÂÔ·V§ë¸ê<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | °òÀs¦Ì§J ¿³ | ¥»¤½¥q¨üÁÜ°Ñ¥[¤¸´IÃÒ¨é¤ÎÀô²y¥Í§Þ¤ë¥ZÁ|¿ì¤§ªk¤H»¡©ú·| |
²Å¦X±ø´Ú²ÄXX´Ú¡G30¨Æ¹êµo¥Í¤é¡G111/12/011.¥l¶}ªk¤H»¡©ú·|¤§¤é´Á¡G111/12/012.¥l¶}ªk¤H»¡©ú·|¤§®É¶¡¡G14 ®É 00 ¤À 3.¥l¶}ªk¤H»¡©ú·|¤§¦aÂI¡G«n´ä®iÄý¤@À]401ÆU4.ªk¤H»¡©ú·|¾Ün°T®§¡G¥»¤½¥q¨üÁÜ°Ñ¥[¤¸´IÃÒ¨é¤ÎÀô²y¥Í§Þ¤ë¥ZÁ|¿ì¤§ªk¤H»¡©ú·|5.ªk¤H»¡©ú·|²³ø¤º®e¡G¤º®eÀɮשó·í¤é·|«á¤½§i©ó¤½¶}¸ê°TÆ[´ú¯¸6.¤½¥qºô¯¸¬O§_¦³´£¨Ñªk¤H»¡©ú·|¤º®e¡G¦³¡Aºô§}¡G www.genomics.com.tw/intro/detail/4177.¨ä¥LÀ³±Ô©ú¨Æ¶µ¡G¬ÛÃö¸ê°T½Ð¦Ü¤½¶}¸ê°TÆ[´ú¯¸¤§ªk¤H»¡©ú·|¤@Äýªí©Îªk»¡·|¶µ¥Ø¤U¬d¾\<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ®çÁH¯èªÅ ¿³ | ¤½§i111¦~10¤ë¥÷¦Ûµ²°]°È³ø§i¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v¤Î³t°Ê¤ñ |
¤½§i111¦~10¤ë¥÷¦Ûµ²°]°È³ø§i¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v¤Î³t°Ê¤ñ²v 1.¨Æ¹êµo¥Í¤é:111/11/292.µo¥Í½t¥Ñ:µo¥Í½t¥Ñ:¦]¥»¤½¥q108¦~«×²Ä2©u°]°È³ø§i¤§t¶Å¤ñ²v°¾°ª¹F78.51%¡A¨ÌÂd¶R¤¤¤ßÃÒÂd¼f¦r²Ä1080101013¸¹¨çn¨D¿ì²z¤½§i3.°]°È¸ê°T¦~«×¤ë¥÷:111¦~10¤ë¥÷4.¦Ûµ²¬y°Ê¤ñ²v:40.195.¦Ûµ²³t°Ê¤ñ²v:35.396.¦Ûµ²t¶Å¤ñ²v:60.937.¦]À³±¹¬I:°§Ct¶Å¤ñ²v8.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | Àu§A±d¥ú ¿³ | ¤½§i¥»¤½¥q111¦~10¤ë¥÷¦Ûµ²°]°È³øªí¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v |
¤½§i¥»¤½¥q111¦~10¤ë¥÷¦Ûµ²°]°È³øªí¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v ¤Î³t°Ê¤ñ²vº[»È¦æ¥i¨Ï¥Î¿Ä¸êÃB«×±¡§Î¤Î¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡ §Î¡C 1.¨Æ¹êµo¥Í¤é:111/11/292.µo¥Í½t¥Ñ:¨Ì·ÓÂd¶R¤¤¤ßÃÒÂd¼f¦r²Ä1060027435¸¹¨ç¿ì²z3.°]°È¸ê°T¦~«×¤ë¥÷:111¦~10¤ë4.¦Ûµ²¬y°Ê¤ñ²v:104.32%5.¦Ûµ²³t°Ê¤ñ²v:74.98%6.¦Ûµ²t¶Å¤ñ²v:56.45%7.¦]À³±¹¬I:¨Ì¥DºÞ¾÷Ãö³W©w¤½§i¡C8.¨ä¥LÀ³±Ô©ú¨Æ¶µ:(1)»È¦æ¥i¨Ï¥Î¿Ä¸êÃB«×±¡§Î (³æ¦ì¡G¥a¤¸)---------------------------------------------------------¶µ¥Ø/¤ë¥÷ 111¦~11¤ë 111¦~12¤ë 112¦~01¤ë--------------------------------------------------------- ¿Ä¸êÃB«× 168,378 165,112 161,846 ¤w¥ÎÃB«× 168,378 165,112 161,846 ÃB«×¾lÃB 0 0 0---------------------------------------------------------(2)111/10¤ë©³¤§¥¼¨Ó¤TӤ뤧²{ª÷¦¬¤ä±¡§Î (³æ¦ì¡G·s¥x¹ô¥a¤¸)---------------------------------------------------------¶µ¥Ø/¤ë¥÷ 111¦~11¤ë 111¦~12¤ë 112¦~01¤ë--------------------------------------------------------- ´Áªìª÷ÃB 298,219 284,026 272,392 ²{ª÷¦¬¤J 67,335 66,515 53,340 ²{ª÷¤ä¥X 81,528 78,149 92,137 ´Á¥½¾lÃB 284,026 272,392 233,595----------------------------------------------------------<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ¥@¬öÂ÷©¤ ¿³ | ¤½§i¥»¤½¥q¸³¨Æ·|¨Mij³q¹L©ÓÅó®üÀs¤G¸¹·¹qªÑ¥÷¦³¤½¥q ¤Î®üÀs |
¤½§i¥»¤½¥q¸³¨Æ·|¨Mij³q¹L©ÓÅó®üÀs¤G¸¹·¹qªÑ¥÷¦³¤½¥q ¤Î®üÀs¤T¸¹·¹qªÑ¥÷¦³¤½¥q¤§®üÀsÂ÷©¤·¹qpµe2A ·³õ (300MW)¡A¦@21®y®MºÞ¦¡¤ô¤U°ò¦ 1.¨Æ¹êµo¥Í¤é:111/11/292.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:®üÀs¤G¸¹·¹qªÑ¥÷¦³¤½¥q¤Î®üÀs¤T¸¹·¹qªÑ¥÷¦³¤½¥q3.»P¤½¥qÃö«Y:µL4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):NA5.¥Dn¤º®e(¸Ñ°£ªÌ¤£¾A¥Î):¥»¤½¥q©ÓÅó®üÀs¤G¸¹·¹qªÑ¥÷¦³¤½¥q¤Î®üÀs¤T¸¹·¹qªÑ¥÷¦³¤½¥q¤§®üÀsÂ÷©¤·¹qpµe2A ·³õ(300MW)¡A¦@21®y®MºÞ¦¡¤ô¤U°ò¦¡C6.¨î±ø´Ú(¸Ñ°£ªÌ¤£¾A¥Î):¨Ì¦X¬ù³W©w¡C7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT:©Ý®i·~°È¡A³Ð³yÀç·~¦¬¤J¡C8.ñq¤§¨ãÅé¥Øªº©Î¸Ñ°£¤§½t¥Ñ:´£¤É¤½¥q¾ãÅé¸gÀçÁZ®Ä¡C9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¥¿¦¡»s³y¦X¬ù¤§Ã±¸p±ÂÅv¸³¨Æªø¥þÅv³B²z¬ÛÃö¨Æ©y¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ¸ô{¥ÍÂå ¿³ | ¤½§i¥»¤½¥q¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î¤Î»È¦æ¥i¨Ï¥Î ¿Ä¸êÃB«×±¡ |
¤½§i¥»¤½¥q¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î¤Î»È¦æ¥i¨Ï¥Î ¿Ä¸êÃB«×±¡§Î 1.¨Æ¹êµo¥Í¤é:111/11/292.¤½¥q¦WºÙ:¸ô{¥ÍÂåªÑ¥÷¦³¤½¥q3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î5.µo¥Í½t¥Ñ:Âd¶R¤¤¤ß©ó110¦~8¤ë23¤éÃÒÂd¼f¦r²Ä1100062664¸¹¨ç¿ì²z¡C(1)¹w¦ô¥¼¨Ó¤TÓ¤ë²{ª÷¦¬¤ä±¡§Î (³æ¦ì¡G¥a¤¸)¶µ¥Ø/¤ë¥÷ 111¦~11¤ë 111¦~12¤ë 112¦~01¤ë--------------------------------------------------------------´Áªì¾lÃB 42,507 42,117 39,325²{ª÷¬y¤J 19,319 22,022 19,717²{ª÷¬y¥X 19,709 24,814 23,769´Á¥½¾lÃB 42,117 39,325 35,273(2)¥»¤½¥q111¦~ºI¦Ü10¤ë©³¤î»È¦æ¥i¨Ï¥Î¿Ä¸êÃB«×±¡§Î (³æ¦ì¡G¥a¤¸)¶µ¥Ø ¹ô§O ¿Ä¸êÃB«× ¤w¥ÎÃB«× ¥¼¨Ï¥ÎÃB«×--------------------------------------------------------------µu´ÁÉ´Ú NTD 204,500 0 204,500ªø´ÁÉ´Ú NTD 64,945 64,945 06.¦]À³±¹¬I:¨Ì¥DºÞ¾÷Ãö³W©w¤½§i¡C7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/29 | ³º¤Ñ¥Íª« ¿³ | ¤½§i¥»¤½¥q¥Ó½Ð¤¤µØ¥Á°êµo©ú±M§Q ¡u§½³¡³Â¾K¾¯-ÂH¤g½Æ¦X²Õ¦Xª« |
1.¨Æ¹êµo¥Í¤é:111/11/292.µo¥Í½t¥Ñ:¥»¤½¥q±µÀò±M§Q¥N²z¤H³qª¾¡A¥»¤½¥q¥Ó½Ð¤§¤¤µØ¥Á°êµo©ú±M§Q¡u§½³¡³Â¾K¾¯-ÂH¤g½Æ¦X²Õ¦Xª«Topical Anesthetic Agent-Clay CompositeCompositions¡v(¥Ó½Ð¸¹110133527¡B¥Ó½Ð¤é2021/09/09)¡A¤wÀò¸gÀÙ³¡´¼¼z°]²£§½(TIPO)®Öã¡C3.¦]À³±¹¬I:µL¡C4.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/28 | °ê¹©¥Íª« ¿³ | ¤½§i°ê¹©¥Í§Þ»PÁú°êBNC Korea¤½¥qñ¸p±ÂÅv¨óij (De |
¤½§i°ê¹©¥Í§Þ»PÁú°êBNC Korea¤½¥qñ¸p±ÂÅv¨óij (Definitive Licensing Agreement)(¸É¥R111/11/22«¤j°T®§ ¬ÛÃö¤º®e»Pì110¦~1¤ë4¤éñq¤§±ÂÅv¦X¬ù×q®t²§) 1.¨Æ¹êµo¥Í¤é:111/11/222.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:BNC Korea Co.,Ltd.3.»P¤½¥qÃö«Y:µL¡C4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):111/11/22~121/11/215.¥Dn¤º®e(¸Ñ°£ªÌ¤£¾A¥Î): (1)°ê¹©¥Í§Þ»PÁú°êBNC Korea Co.,Ltd.(¥H¤U²ºÙBNC Korea)ñ¸p±ÂÅv¨óij (Definitive Licensing Agreement)¡A±ÂÅvBNC Korea¤½¥q©ó±ÂÅv°Ï°ì¨ú±oÃĪ«¤W¥«¡@ ³\¥i«á¶i¦æ¾P°â¤Î±À®i±ÂÅv¤§²£«~¡C°ê¹©¥Í§Þ»PBNC Korea¥ý«e©ó110¦~1¤ë4¤éñ¸p ·s«aªÍª¢·sÃĤ§¶}µo¦X§@¤Î±ÂÅv¦X¬ù¡C (2)±ÂÅv²£«~:Antroquinonol(°Ó¼ÐHOCENA)¡C (3)±ÂÅv¨Ï¥Î¾AÀ³¯g: ©óªvÀø·s«aªÍª¢(COVID-19)¡CÂù¤è¦P·N¸Ó±ÂÅv¨Ï¥Î¤§¾AÀ³¯g¸gÂù¤è®Ñ±¦P·N¥iÂX ®i¦Ü¨ä¥L¾AÀ³¯g¡C (4)±ÂÅv°Ï°ì:«nÁú¡B¤Ú¦è¡B¤g¦Õ¨ä¤Î¦L¥§¡C (5)¦¹±ÂÅv¨óij(Definitive Licensing Agreement) ¦Xp±ÂÅv¨½µ{ª÷¬°1,500¸U¬ü¤¸¡A ¨ä¤¤¥]§tñ¬ù¨½µ{ª÷¬üª÷400¸U¤¸(°ê¹©¥Í§Þ¤w©ó110¦~1¤ë8¤é¤Î2¤ë26¤é¦¬¨ì¦@¬üª÷ 400¸U¤¸)¡A¥H¤Î°õ¦æ·s«aªÍª¢¤T´ÁÁ{§É¤ÎÀò±oÃÄÃÒ(NDA approval)¤§¨½µ{ª÷1100¸U ¬ü¤¸¡C (6)Y·sÃĤW¥«¡A°ê¹©±N¾P³f»PBNC Korea¡A¥t¥~¤]¨Ì¬ùÀò±o¾P°âÅv§Qª÷(royalty)¡F Y²Å¦XÂù¤è¬ù©w¤§±ø¥ó¡AÂù¤è±N¥tq¥Í²£¨óij¡A°ê¹©±N±Â»PBNC Korea»s³y¤§Åv§Q¡A °ê¹©±N¾P°âì®Æ(API)¤©BNC Korea¡C6.¨î±ø´Ú(¸Ñ°£ªÌ¤£¾A¥Î):¨ÌÂù¤è¦X¬ù³W©w¡C7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT: ÂǥѹïBNC Korea¤§°ê»Ú±ÂÅv¡A¥iѺª`¥»¤½¥q¥¼¨ÓÀç·~¦¬¤J¡A¹ï¤½¥q°]°È¡B·~°È¤Î «áÄò¥þ²y¤§·sÃıÀ®i¦³¥¿±¤§§U¯q¡C8.ñq¤§¨ãÅé¥Øªº©Î¸Ñ°£¤§½t¥Ñ: ÂX®i¥»¤½¥q¶}µo¤§·s«aªÍª¢(COVID-19)·sÃÄAntroquinonol(°Ó¼ÐHOCENA)¤§°ê»Ú ±ÂÅv¥«³õ¡C9.¨ä¥LÀ³±Ô©ú¨Æ¶µ: (1)¥»¦¸¦X¬ùÅܧ󪺮t²§³¡¥÷¦p¤U: (a)±ÂÅv°Ï°ìÅܧó¡G±Nì¥ý±ÂÅv¥|Ó°ê®a¤¤ªº«Xù´µ¤Î¯Q§JÄõ¡AÅܧ󬰤ڦè¤Î¦L¥§¡C (b)¨½µ{ª÷±ø¥óÅܧó¡G¦X¬ù±ÂÅvª÷Á`ª÷ÃB¥Ñ1,800¸U¬ü¤¸Åܧó¬°1,500¸U¬ü¤¸¡C ¨ä¤¤400¸U¬ü¤¸Ã±¬ù¹w¥I´Ú(upfront payment)½Õ¾ã¬°¨½µ{ª÷(milestone payment)¡C (c)·s¼Wq¦³±ø¥ó±ÂÅvBNC Korea·sÃÄ»s³yÅv§Q¡G©óBNC Koreaº¡¨¬Âù¤è¬ù©w±ø¥ó«á¡A °ê¹©±N¨ÑÀ³API¤©BNC Korea¶i¦æ»s³y¡C (d)©ú½T¬ù©w¨ÑÀ³¤è¦¡¡G·sÃĤW¥«²Ä1¦~±N¥Ñ°ê¹©¨ÑÀ³¾¯«¬ÃÄ(Drug)¡Aª½¨ìBNC Korea¤§¾P°â¡A¥H¤Î¨ä¤u¼t³]³Æ²Å¦XÂù¤è¬ù©wn¨D¤§»s³y±ø¥ó¡A¥[¤WÂù¤è§¹¦¨ ¡u»s³y¦X¬ù¡v¡]Manufacture Agreement¡^¤§Ã±¸p«á¡A©l±ÂÅvBNC Korea§Q¥Î¦V¥» ¤½¥q±ÄÁʪºAPI»s³yDrugªº»s³yÅv§Q¡C (2)¥»¤½¥q±N³W¹ºÄ~Äò¦VFDA¥Ó½Ð¤T´ÁÁ{§É¸ÕÅç¡A¥H¥Ó½ÐNDA¨ú±oÃÄÃҤηsÃĤW¥«¡@ ¬°¥Ø¼Ð¡C (3)·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
2022/11/28 | µØ¼w°Ê¯à ¿³ | ¤½§i¥»¤½¥qµù¾P¨îû¤uÅv§Q·sªÑ´î¸êÅܧóµn°O§¹¦¨ |
1.¥DºÞ¾÷Ãö®Öã´î¸ê¤é´Á:111/11/242.¿ì²z¸ê¥»Åܧóµn°O§¹¦¨¤é´Á:111/11/243.¹ï°]°È³ø§i¤§¼vÅT¡]§t¹ê¦¬¸ê¥»ÃB»P¬y³q¦b¥~ªÑ¼Æ¤§®t²§»P¹ï¨CªÑ²bȤ§¼vÅT¡^:(1)¥»¤½¥q´î¸ê«e¹ê¦¬¸ê¥»ÃB¬°·s¥x¹ô1,008,378,750¤¸¡A¬y³q¦b¥~ªÑ¼Æ¬°100,837,875ªÑ ¡A¨CªÑ²bȬ°·s¥x¹ô7.89¤¸¡C(2)¥»¦¸µù¾P´î¸ê·s¥x¹ô350,000¤¸¡Aµù¾PªÑ¥÷35,000ªÑ¡C(3)¥»¤½¥q´î¸ê«á¹ê¦¬¸ê¥»ÃB¬°·s¥x¹ô1,008,028,750¤¸¡A¬y³q¦b¥~ªÑ¼Æ¬°100,802,875ªÑ ¡A¨CªÑ²bȬ°·s¥x¹ô7.9¤¸¡C4.¹wp´«ªÑ§@·~pµe:¤£¾A¥Î¡C5.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¨CªÑ²bÈ«Y¨Ì³Ìªñ¤@´Á(111¦~²Ä¤G©u)·|p®v®Ö¾\°]°È³ø§ipºâ¡C<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸> |
|
|